Chief Scientific Officer

Dr. Sheila A. Mathias has more than 20 years of leadership experience in the pharmaceutical  industry accelerating drug development. She brings extensive global regulatory affairs strategic guidance and clinical development experience having worked across a range of  therapeutic areas, including pain management, addiction medicine, and dermatology. This experience has spanned across big pharma, mid-sized, to start-up biotechnology companies. Most recently, she held the position Senior Director Global Regulatory Affairs at Sun Pharma Advanced Research Company. Sheila has held increasing roles of responsibilities, entering the pharmaceutical industry at Merck US Human Health in the position of Medical Science Liaison. Dr. Mathias transitioned into Regulatory Affairs at Aventis Pharmaceuticals and has successfully  brought multiple products through regulatory approval.  Dr. Mathias received a B.S in Zoology from Howard University, a PhD in Neurophysiology from Meharry Medical College, an executive  MBA from Saint Joseph’s University, and  a JD from Northwestern California University School of Law.  Since 2018 she has served on the Advisory Board for Tennessee State University Department of Biology.